microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study

BACKGROUND: Around 70% of breast cancers (BCs) are estrogen receptor-α (ERα)-positive. Adjuvant endocrine therapy is used to reduce estrogen levels and inhibit signal transduction through the ER. The anti-estrogen drugs that are most commonly used in endocrine therapy belong to the selective ER modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiruddin, Alfiah, Massi, Muhammad Nassrum, Islam, Andi Asadul, Patellongi, Ilhamjaya, Pratama, Muhammad Yogi, Sutandyo, Noorwati, Natzir, Rosdiana, Hatta, Mochammad, Md Latar, Nani Harlina, Wahid, Syarifuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case-controlled Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767262/
https://www.ncbi.nlm.nih.gov/pubmed/35079352
http://dx.doi.org/10.1016/j.amsu.2021.103092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767262/
https://www.ncbi.nlm.nih.gov/pubmed/35079352
http://dx.doi.org/10.1016/j.amsu.2021.103092

Ejemplares similares